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Abstract
Background: Obesity is associated with a relative increase in bacterial phyla like ﬁrmicutes, which helps in the colonization of Clostridioides Difﬁcile.
Hypothesis: Individuals with increased BMI (greater than 25) are more susceptible to severe Clostridioides Difﬁcile
infection (CDI).
Methods: Data was collected by retrospective chart query. Severe CDI was deﬁned as a white blood cell count of more
than 15,000 (x 109 cells/L) or serum creatinine levels greater than 1.5 mg/dL. To examine the association between the
primary outcome (severe CDI) and BMI, the factors of age, gender, albumin level, ICU admission, antibiotic use within 3
months of admission, diabetes, and hypertension were also considered. Patients with chronic kidney disease, end-stage
liver disease, pregnancy, inﬂammatory bowel disease, previous gastrointestinal surgeries, active malignancy, and
immunosuppressed were excluded.
Results: 219 patients were included in the ﬁnal study. Of these 52.8% of patients had severe CDI, and 47.2% had nonsevere CDI. Compared to normal-weight patients, risk of severe CDI was not inﬂuenced by being obese (OR ¼ 1.26,
p ¼ 0.5119), overweight (OR ¼ 1.65, p ¼ 0.21), or underweight (OR ¼ 1.05, p ¼ 0.9383). Males had higher odds of having
severe CDI when compared with females (OR ¼ 1.76, 95% CI ¼ 1.03 to 3.01, p ¼ 0.0395). Albumin levels greater than
3.0 mg/dL were associated with lower odds of having severe CDI (OR ¼ 0.41, 95% CI ¼ 0.27 to 0.62, p< 0.0001).
Conclusion: BMI of an individual does not appear to be associated with the severity of CDI.
Keywords: Clostridium difﬁcile, Clostridioides difﬁcile, Clostridium difﬁcile diarrhea, Clostridioides difﬁcile diarrhea,
Clostridium difﬁcile infection, Host-pathogen interactions, Obesity, Dysbiosis, Retrospective studies

1. Introduction

C

lostridioides difﬁcile, previously known as
Clostridium difﬁcile is the most common cause
of antibiotic-associated diarrhea, as well as healthcare-associated diarrhea.1 In the early 2000s, a rise
in Clostridioides difﬁcile infections (CDI) was
observed due to the emergence of the highly virulent ribotype 007 along with the use of more sensitive assays for diagnosis.2,3 During the period from

2011 through 2017, the estimated national burden of
CDI and associated hospitalizations decreased
owing to an overall decline in healthcare-associated
infections attributable to improved hospital hygiene
practices.3 Despite an observed decline in the total
number of cases, the magnitude of mortality and
morbidity by CDI remains high. In the year 2017
CDC reported 223,900 new cases of Clostridioides
difﬁcile along with 12,800 deaths due to CDI.4
Recent evidence suggests that there is a rising
number of community-acquired CDI as compared
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to hospital-acquired CDI.5 Traditionally, antibiotic
use, advanced age, hospitalization, and gastrointestinal surgery are associated with increased risk
for CDI.1 But recently it has been observed that the
patients with community-acquired CDI are
comparatively younger with fewer comorbidities,
lesser antibiotics exposure, and a lower number of
conventional risk factors for CDI.5
With this changing landscape of CDI, researchers
are pursuing the presence of additional novice risk
factors. Researchers across the world have identiﬁed
obesity, chronic opioid use, statins, and antidepressant use are variables of interest for possible
risk factors for CDI.6 A retrospective cohort study by
Mora et al. showed a statistically signiﬁcant increase
in CDI cases among hospitalized patients with a
moderate to a high dose of opioid use, likely secondary to the slowing of peristalsis.7 A greater
incidence of severe CDI and CDI-associated
morbidity has been observed in patients of inﬂammatory bowel disease (IBD). The derangement of
intestinal microbiota in IBD patients has been
attributed to be the cause of their greater susceptibility to severe CDI.8 A similar dysbiosis of intestinal microbiota is seen in patients with antibiotic use.
In recent times, it has become more evident that
obese individuals display paucity in the diversity of
intestinal micro-organisms.9 Therefore, it has been
hypothesized that obesity might be an independent
risk factor for severe CDI. Obesity remains one of
the most common comorbidities among our patients, both inpatient and outpatient practice. Thus,
we investigated the association of obesity with severe CDI, in this study.

2. Methods
2.1. Deﬁnitions used in the study
A case of CDI was deﬁned as a positive C. difﬁcile
toxin assay or a positive C. difﬁcile molecular assay
(PCR) of a stool specimen at the time of symptoms
as per standard nomenclature. Severe CDI was
deﬁned as WBC count >15,000 cells/ml or serum
creatinine >1.5 mg/dl as per Infectious Diseases
Society of America guidelines.10
We categorized patients as underweight who had
BMI <18.5, normal weight with BMI 18.5 to <25,
overweight with BMI 25.0 to <30, and obese with
BMI >30.0.11
2.2. Inclusion and exclusion criteria
Inclusion criteria included 1) age above 18 years
and b) Clostridioides difﬁcile diarrhea: the presence

of diarrhea with stool positive for Clostridioides
difﬁcile toxin.
Our exclusion criteria were 1) diagnosis of active
malignancy 3) ongoing chemotherapy 4) ongoing
cause of immunosuppression (HIV, transplant, on
chronic steroids, immunodeﬁciency syndromes) 5)
diagnosis of chronic kidney disease (CKD) or endstage kidney disease, 6) pregnancy 7) history of inﬂammatory bowel disease and 8) history of previous
gastrointestinal surgeries. CKD was speciﬁcally
chosen to be one of the exclusion criteria, as the
deﬁnition of severe CDI included creatinine of more
than 1.5 mg/dL. Any patients with baseline creatinine more than or equal to 1.5 mg/dL due to CKD
would have been falsely classiﬁed in the category of
severe CDI.
2.3. Data collection
We requested records of 1000 patients admitted to
OSF hospitals, with a diagnosis of CDI going back
from 31st May 2020 by placing a query in the electronic health data system. After applying exclusion
criteria, 219 patients met the criteria for inclusion in
the study.
The other variables collected from the electronic
medical record were age at the time of admission,
gender, weight in kilograms, height in meters, hypertension status, diabetes mellitus status, white
blood cell count (WBC) on admission, neutrophil
count on admission, albumin levels on admission,
creatinine level on admission, current use of proton
pump inhibitors, antibiotic use in last 3 months, ICU
admission in 3 months before current diagnosis,
required ICU care during current admission or not.
The variable BMI was computed using the weight in
kilograms (kg) and the height in meters (m) using
the formula BMI ¼ weight in kg/(height in meters)
^2. Since creatinine and WBC formed part of the
outcome, these two were not included as covariates
in the logistic regression model.
2.4. Statistical analysis
All statistical analyses were performed using SAS
software version 9.4 (SAS Institute Inc., Cary, NC,
USA). In this study, means and standard deviations
were reported for continuous variables, and percentage values were reported for categorical variables. Chi-square tests or exact Chi-square tests
were used to check on the associations with categorical variables. Wilcoxon rank-sum tests were
used to compare continuous variables. Other
appropriate descriptive statistics, such as frequency,
median, lower quartile (q25), upper quartile (q75),

minimum, and maximum were used to summarize
the data results.
To examine the association between the primary
outcome severe C. difﬁcile infection and BMI, the
factors of age, gender, albumin level, requiring ICU
admission, current use of proton pump in, antibiotic
use within previous 3 months of admission, diabetes
mellitus type 2 and hypertension were all considered.
The univariate analysis and the univariate logistic
regression models were ﬁrst performed, and covariates whose p-value  0.25 were included in the
multiple logistic regression model. The stepwise
model selection was performed, and the ﬁnal model
was constructed. Analysis giving p< 0.05 value is
considered a statistically signiﬁcant test. All values
are expressed as median (IQR).

3. Results
Of 219 individuals who met the inclusion criteria,
106 (48.4%) were males and 113 (51.6%) were females, the median age was 69.0 (59.0e81.0) years,
mean weight in kg was 79.8 ± 24.6, mean height in
meters 1.7 ± 0.1 and mean BMI in Kg/m2
27.9 ± 8.1.24 (7.9%) patients were under-weight and
nearly one-third (107,35.4%) met the criteria for

obesity, and nearly half (115, 52.8%) met criteria for
severe CDI. Approximately one-third of the patients, 61 (27.9%) needed ICU admission. Of these,
17 patients with CDI had a history of ICU admission
in the past 3 months. Table 1 depicts the patient
characteristics when comparing severe CDI with
non-severe infection.
Compared to normal weight patients, risk of severe CDI was not inﬂuenced by being obese
(OR ¼ 1.26, p ¼ 0.5119), overweight (OR ¼ 1.65,
p ¼ 0.21), or underweight (OR ¼ 1.05, p ¼ 0.9383,
Table 2). Males had higher odds of having severe
CDI when compared with females (OR ¼ 1.76, 95%
CI ¼ 1.03 to 3.01, p ¼ 0.0395). We also observed that
with every unit (1 mg/dL) increase in albumin the
odds of having severe C. difﬁcile infection decreased.
Albumin levels greater than 3.0 mg/dL were associated with lower odds of having severe CDI
(OR ¼ 0.41, 95% CI ¼ 0.27 to 0.62, p< 0.0001). Patients who required ICU level care were associated
with higher odds of having severe C. difﬁcile infection when compared with non-ICU patients
(OR ¼ 2.30, 95% CI ¼ 1.24 to 4.27, p ¼ 0.0085), which
is an expected association.
In the ﬁnal model (Table 3), after multivariate logistic regression and adjusting for all other factors,

Table 1. Patient characteristics.
Variables

Gender
Female
Male
Missing
Age
N
Median (min - max)
Median (q25 - q75)
Mean ± SD
Missing
Diabetes
No
Yes
Missing
Hypertension
No
Yes
Missing
Proton Pump Inhibitor use
No
Yes
Missing
Antibiotic use in last 3 months
No
Yes
Missing
ICU admission in last 3 months
No

Severe C. difﬁcile infection

P Value

Total
N ¼ 218(%)

No
N ¼ 103(%)

Yes
N ¼ 115(%)

113 (100)
105 (100)
0

61 (54.0)
42 (40.0)
0

52 (46.0)
63 (60.0)
0

218
69.0 (23.0e99.0)
69.0 (59.0e81.0)
66.6 ± 18.0
0

103
68.0 (23.0e98.0)
68.0 (59.0e78.0)
66.2 ± 17.3
0

115
70.0 (23.0e99.0)
70.0 (59.0e81.0)
67.0 ± 18.7
0

164 (100)
54 (100)
0

77 (47.0)
26 (48.1)
0

87 (53.0)
28 (51.9)
0

78 (100)
140 (100)
0

39 (50.0)
64 (45.7)
0

39 (50.0)
76 (54.3)
0

132 (100)
86 (100)
0

56 (42.4)
47 (54.7)
0

76 (57.6)
39 (45.3)
0

106 (100)
112 (100)
0

50 (47.2)
53 (47.3)
0

56 (52.8)
59 (52.7)
0

201 (100)

95 (47.3)

106 (52.7)

0.039

0.656

0.879

0.543

0.077

0.982

0.987
(continued on next page)
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Table 1. (continued )
Variables

Yes
Missing
WBC
N
Median (min - max)
Median (q25 - q75)
Mean ± SD
Missing
Neutrophil
N
Median (min - max)
Median (q25 - q75)
Mean ± SD
Missing
Albumin
N
Median (min - max)
Median (q25 - q75)
Mean ± SD
Missing
Required ICU
No
Yes
Missing
Calculated BMI
N
Median (min - max)
Median (q25 - q75)
Mean ± SD
Missing
Weight status
Underweight
Normal
Overweight
Obese
Missing

Severe C. difﬁcile infection

P Value

Total
N ¼ 218(%)

No
N ¼ 103(%)

Yes
N ¼ 115(%)

17 (100)
0

8 (47.1)
0

9 (52.9)
0

187
10.0 (1.5e47.0)
10.0 (6.9e14.2)
11.8 ± 7.1
31

83
7.8 (1.5e14.9)
7.8 (5.6e9.9)
7.8 ± 2.8
20

104
13.6 (3.0e47.0)
13.6 (9.6e17.6)
15.0 ± 7.9
11

211
10.5 (1.4e45.2)
10.5 (6.3e15.9)
12.4 ± 7.6
7

99
6.7 (1.4e12.3)
6.7 (4.9e9.5)
7.0 ± 2.6
4

112
15.8 (4.0e45.2)
15.8 (12.3e21.8)
17.1 ± 7.5
3

210
3.0 (1.3e4.7)
3.0 (2.4e3.6)
3.0 ± 0.7
8

98
3.3 (1.9e4.5)
3.3 (2.8e3.7)
3.2 ± 0.6
5

112
2.7 (1.3e4.7)
2.7 (2.3e3.3)
2.8 ± 0.7
3

157 (100)
61 (100)
0

83 (52.9)
20 (32.8)
0

74 (47.1)
41 (67.2)
0

217
26.0 (12.8e56.7)
26.0 (21.9e32.7)
27.9 ± 8.1
1

103
25.7 (15.2e56.7)
25.7 (21.8e33.2)
28.1 ± 8.5
0

114
26.5 (12.8e51.9)
26.5 (22.4e32.3)
27.7 ± 7.9
1

20
70
51
76
1

8 (40.0)
37 (52.9)
20 (39.2)
38 (50.0)
0

12
33
31
38
1

< 0.001

< 0.001

< 0.001

0.008

0.978

0.415
(100)
(100)
(100)
(100)

(60.0)
(47.1)
(60.8)
(50.0)

Table 2. Univariate analysis.
Variables

Severe Cdiff
Total
N ¼ 218 (%)

Gender
Female
Male
Missing
Required ICU
No
Yes
Missing
Protonic
No
Yes
Missing
Antibiotic within 3 months
No
Yes
Missing
Diabetes
No

113 (100)
105 (100)
0
157 (100)
61 (100)
0

No
N ¼ 103 (%)
61 (54.0)
42 (40.0)
0
83 (52.9)
20 (32.8)
0

Yes
N ¼ 115 (%)

P Value
0.039

C

0.008

C

0.077

C

0.982

C

0.879

C

52 (46.0)
63 (60.0)
0
74 (47.1)
41 (67.2)
0

132 (100)
86 (100)
0

56 (42.4)
47 (54.7)
0

76 (57.6)
39 (45.3)
0

106 (100)
112 (100)
0

50 (47.2)
53 (47.3)
0

56 (52.8)
59 (52.7)
0

164 (100)

77 (47.0)

87 (53.0)
(continued on next page)
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Table 2. (continued )
Variables

Severe Cdiff

Yes
Missing
Hypertension
No
Yes
Missing
ICU admission within 3 months
No
Yes
Missing
Age
N
Median (min - max)
Median (q25 - q75)
Mean ± SD
Missing
WBC on admission
N
Median (min - max)
Median (q25 - q75)
Mean ± SD
Missing
Neutrophil
N
Median (min - max)
Median (q25 - q75)
Mean ± SD
Missing
Albumin
N
Median (min - max)
Median (q25 - q75)
Mean ± SD
Missing
Calculated BMI
N
Median (min - max)
Median (q25 - q75)
Mean ± SD
Missing
Weight status
Underweight
Normal
Overweight
Obese
Missing

Total
N ¼ 218 (%)

No
N ¼ 103 (%)

Yes
N ¼ 115 (%)

54 (100)
0

26 (48.1)
0

28 (51.9)
0

78 (100)
140 (100)
0
201 (100)
17 (100)
0
218
69.0 (23.0e99.0)
69.0 (59.0e81.0)
66.6 ± 18.0
0
187
10.0 (1.5e47.0)
10.0 (6.9e14.2)
11.8 ± 7.1
31
211
10.5 (1.4e45.2)
10.5 (6.3e15.9)
12.4 ± 7.6
7

39 (50.0)
64 (45.7)
0

0.543

C

0.987

C

0.656

W

39 (50.0)
76 (54.3)
0

95 (47.3)
8 (47.1)
0

106 (52.7)
9 (52.9)
0

103
68.0 (23.0e98.0)
68.0 (59.0e78.0)
66.2 ± 17.3
0
83
7.8 (1.5e14.9)
7.8 (5.6e9.9)
7.8 ± 2.8
20
99
6.7 (1.4e12.3)
6.7 (4.9e9.5)
7.0 ± 2.6
4

115
70.0 (23.0e99.0)
70.0 (59.0e81.0)
67.0 ± 18.7
0
< 0.001

W

< 0.001

W

< 0.001

W

104
13.6 (3.0e47.0)
13.6 (9.6e17.6)
15.0 ± 7.9
11
112
15.8 (4.0e45.2)
15.8 (12.3e21.8)
17.1 ± 7.5
3

210
3.0 (1.3e4.7)
3.0 (2.4e3.6)
3.0 ± 0.7
8

98
3.3 (1.9e4.5)
3.3 (2.8e3.7)
3.2 ± 0.6
5

112
2.7 (1.3e4.7)
2.7 (2.3e3.3)
2.8 ± 0.7
3

217
26.0 (12.8e56.7)
26.0 (21.9e32.7)
27.9 ± 8.1
1

103
25.7 (15.2e56.7)
25.7 (21.8e33.2)
28.1 ± 8.5
0

114
26.5 (12.8e51.9)
26.5 (22.4e32.3)
27.7 ± 7.9
1

20
70
51
76
1

8 (40.0)
37 (52.9)
20 (39.2)
38 (50.0)
0

12
33
31
38
1

(100)
(100)
(100)
(100)

P Value

0.978

W

0.415

C

(60.0)
(47.1)
(60.8)
(50.0)

+

Exact test
t-test; CChi-square test;

T

W

Wilcoxon rank-sum test

Table 3. Logistic regression models result.
Variable

Unadjusted odds ratio

95% CI

Gender Male vs Female
Albumin
Required ICU Yes vs No
Protonic Yes vs No
BMI
Weight status new
Obese vs Normal
Overweight vs Normal
Underweight vs Normal

1.76
0.41
2.30
0.61
0.99

1.03
0.27
1.24
0.35
0.96

3.01
0.62
4.27
1.06
1.03

P-value

1.12
1.74
1.68

0.59
0.84
0.61

2.15
3.61
4.62

0.0395
<0.0001
0.0085
0.0780
0.6693
0.4185
0.7301
0.1391
0.3132
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we do not have evidence to conclude that weight
status was associated with severe CDI.

4. Discussion
CDI is the most common cause of nosocomial
diarrhea and is quickly becoming a community-acquired disease.10 Antibiotic use and proton pump
inhibitors are established risk factors for CDI but as
the disease is now affecting traditionally low-risk
patients, there have been attempts to identify novel
risk factors. It is worth looking at risk factors that are
not only contributing to the acquisition of the
infection but also the severity of the disease.6
The causative organism of CDI is Clostridioides
difﬁcile which is a spore-forming, gram-positive,
obligate anaerobic bacillus of the Firmicutes phylum.
It is a part of normal human gut microbiota and its
growth is kept under control by other more dominant
anaerobes. As there is a disruption in the composition
of intestinal microbiota, the commensal relation is
lost and C. difﬁcle colonizes the intestines. Human
gut microbiota consists of over 1 trillion microorganisms and most of these organisms reside in the
colon. Normal gut ﬂora contains 60e80% Firmicutes
and 20e40% Bacteroidetes.12 An unhealthy alteration
in the gut microbiome is called dysbiosis. In recent
years, intestinal dysbiosis has been associated with
multiple disease processes including CDI. Patients
with obesity display an increase in the percentage
population of ﬁrmicutes and a decrease in bacteroidetes population.13 Ley et al. demonstrated a 50%
decrease in the bacteroidetes and a concomitant increase in ﬁrmicutes in the gut microbiota of mice with
homozygous aberrant leptin gene as compared to
wild-type or heterozygous mice with p< 0.005.14 Adipose tissue produces an adipocytokine called leptin
which behaves as a cytokine as well as a hormone.
Leptin levels are expectedly elevated in obese individuals due to the presence of excess adipose tissue.
Via its cytokine-like action, leptin induces a state of
chronic low-grade inﬂammation in the obese,
reducing their immunity.15,16 These pathophysiological milieus in obese individuals may place them at an
increased risk of severe CDI.
Voth et al. studied the risk of obesity and severe
CDI in populations afﬂicted with IBD. In that study,
it was reported that the risk of severe CDI is 3 and 4
times higher in overweight (BMI >25.0e29.9 kg/m2)
individuals as compared to underweight/normal
individuals (BMI <24.9 kg/m2), respectively. The
association of BMI >30.0 kg/m2 and severe CDI did
not reach statistical signiﬁcance but an odds ratio of
1.99 was strongly suggestive of a possible
relationship.6

Another caseecontrol study reported a strong
association between obesity and CDI. In the study,
patients with CDI had higher mean BMI when
compared to the ones without CDI (33.6 vs 28.9,
respectively; p< 0.001). However, the relationship
between the severity of CDI and obesity was not
assessed.17
In a retrospective cohort study of 132 communityacquired C. difﬁcile infection (CO- CDI) patients, it
was found that patients were twice as likely to be
obese when compared to the general population
(35% vs 23%), but statistical signiﬁcance was not
reached.8 However, in the same year, a caseecontrol
age and gender-matched study of 189 subjects by
Punni et al. assessed the effect of obesity and CDI
and did not ﬁnd an association.18
The largest retrospective cohort study done to ﬁnd
an association between CDI and obesity included
1,426,807 post-operative patients and surprisingly
found that obesity was associated with reduced risk
of CDI at 30 days post-surgery in a stepwise manner
(1.11%, 0.56%, 0.39%, 0.35%, 0.33% and 0.36% from
the lowest to the highest BMI group, respectively;
p< 0.001 for trend).19
In 2017 Mulki et al. performed a retrospective
cohort study and demonstrated that BMI >35 kg/m2
was 1.7-fold more likely to be associated with severe
CDI compared to a BMI 20e35 kg/m2 (P< 0.005) and
was an independent predictor of severe CDI
(P ¼ 0.038). However, unlike our study, they used
much broader criteria to deﬁne severe CDI. They
classiﬁed the cases as severe if they met any of the
criteria of serum albumin <3 g/dL, severe abdominal tenderness/distention, systolic blood pressure
<100 mmHg, temperature >38.5  C, mental status
change, serum lactate levels >2.2 mmol/L or had
end-organ failure attributable to CDI.20
A retrospective cohort study using the Nationwide
Emergency Department Sample (NEDS) from 2017
showed both extremes of BMI, i.e BMI<19 and
BMI>40 are associated with increased in-hospital
mortality with CDI.21
Our study results did not show an association
between higher BMI and risk of severe CDI. Current
evidence on the association between severe CDI and
obesity is somewhat conﬂicted but leans towards the
increased likelihood of CDI in obese individuals
(BMI >30kg/m2). A plausible explanation of the lack
of expected evidence correlating severe CDI with
obesity is the likelihood of under-dosing antibiotics
in obese individuals.22
Secondarily, we observed in our study that the
male gender is associated with the risk of having
severe CDI. Traditionally male gender has not been
established as a risk factor for CDI or severe CDI.

The existing literature does not have much evidence
on gender predilection of CDI. A population-based
cross-sectional study in Spain showed no difference
in the incidence of CDI between males and females
below 45 years but above 45 years.23
Our study also showed low albumin level is
associated with a greater risk of severe CDI. There
are two possible explanations for this association.
Low albumin is an indicator of poor nutritional
status and lowered immunity making the patient
more prone to severe infection. Whilst it is also
possible that lower albumin is an inﬂammatory
marker for disease severity.

5. Conclusion
There are very few studies dedicated to investigating the association of severe CDI and obesity.
The ﬁndings of our study do not support an
increased risk of severe CDI in patients with obesity,
suggesting the possibility of confounding factors
inﬂuencing previous literature on the subject. The
emergence of other factors such as male gender and
albumin levels also suggest the possibility of
heightened inﬂuence of deranged pharmacokinetics
in individuals on antibiotics, which may merit
exploration by studies designed to assess these
factors. The current ﬁndings highlight the need for
more studies in this area with larger datasets.
5.1. Limitations of the study
We fully acknowledge the limitations arising out
of the study design and those inherent to the dataset
used. We had strict exclusion criteria but in a
retrospective hospital cohort like the current study,
it is not possible to eliminate all confounding factors
even after using a regression model with multiple
factors. Our study also had a relatively small sample
size. We could not include CKD patients in our
study as elevated baseline creatinine levels would
have confounded our deﬁnition of severe CDI. So, it
is possible that this study could not include quite a
few cases of severe CDI. One option was to use
absolute rise in creatinine in the patients admitted
with CDI, but it was out of the scope of this study.
Moreover, community-acquired and hospital-acquired CDI could not be discerned from our data.
The risk factors may be different for the acquisition
of these two different modes of infection.
The patients are from multiple hospitals in one
catchment area. Virulence of the prevalent C diff
strain in the community would impact its infectivity
and severity. For eg. C. difﬁcile ribotype 027 is a
hyper-virulent strain and has been associated with

49

increased morbidity in the community.24 Besides,
determining the strain of C. difﬁcile was beyond the
scope of our study.
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